Difference between revisions of "Part:BBa K2669000:Experience"
m |
m |
||
| Line 1: | Line 1: | ||
| − | + | <html> | |
__NOTOC__ | __NOTOC__ | ||
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | ||
| Line 31: | Line 31: | ||
<!-- End of the user review template --> | <!-- End of the user review template --> | ||
<!-- DON'T DELETE --><partinfo>BBa_K2669000 EndReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K2669000 EndReviews</partinfo> | ||
| + | |||
| + | </html> | ||
Revision as of 11:39, 30 September 2018
__NOTOC__
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
===Applications of BBa_K2669000===
After transforming our cells with a low copy amplicilin plasmid containing this composite part, cell lysis and affinity chromotography were used to extract UnaG from our cells. Please note: The exact procedure can be found here Bilirubin tests (addition of a small amount of bilirubin to samples) allowed us to see if the UnaG was present in our samples, since as mentioned earlier UnaG fluoresces in the presence of bilirubin.
Figure 2: Bilirubin test before/after affinity chromatography. Going from right to left the samples are:
- Lysed sample of the “bad” part before AC
- Lysed sample of the “good” part before AC
- "Bad" part after AC
- "Good" part after AC